3-[[3-(4-methylpiperazine-1-carbonyl)phenyl]methyl]benzo[f]benzotriazole-4,9-dione
C23H21N5O3 — CID 122193596
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[[3-(4-methylpiperazine-1-carbonyl)phenyl]methyl]benzo[f]benzotriazole-4,9-dione
3-[[3-(4-methylpiperazine-1-carbonyl)phenyl]methyl]benzo[f]benzotriazole-4,9-dione (PubChem CID 122193596) has the molecular formula C23H21N5O3 and a molecular weight of 415.45 g/mol. Its IUPAC name is 3-[[3-(4-methylpiperazine-1-carbonyl)phenyl]methyl]benzo[f]benzotriazole-4,9-dione.
Molecular Properties
| Compound Name | 3-[[3-(4-methylpiperazine-1-carbonyl)phenyl]methyl]benzo[f]benzotriazole-4,9-dione |
|---|---|
| PubChem CID | 122193596 |
| Molecular Formula | C23H21N5O3 |
| Molecular Weight | 415.45 g/mol |
| Exact Mass | 415.16 |
| IUPAC Name | 3-[[3-(4-methylpiperazine-1-carbonyl)phenyl]methyl]benzo[f]benzotriazole-4,9-dione |
| SMILES | CN1CCN(C(=O)c2cccc(Cn3nnc4c3C(=O)c3ccccc3C4=O)c2)CC1 |
| InChI | InChI=1S/C23H21N5O3/c1-26-9-11-27(12-10-26)23(31)16-6-4-5-15(13-16)14-28-20-19(24-25-28)21(29)17-7-2-3-8-18(17)22(20)30/h2-8,13H,9-12,14H2,1H3 |
| InChIKey | XHMWOYOVGULXFN-UHFFFAOYSA-N |
| XLogP | 1.49 |
| TPSA | 88.40 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 415.45 |
| LogP ≤ 5 | 1.49 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'quinone_A(370)', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122193596 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.